6Welage LS. Pharmacologic features of proton pump inhibitors and their potential relevance to clinical practice[J]. Gastroenterol Clin North Am, 2003,32 (Suppl3) : S25.
7Courts RT, Urichuk LJ. Polymorphic cytochromes P450 and drugs used in psychiatry[J]. Cell Mol Neurobiol, 1999.19(3) :325.
8Regardh C G, Andersson T, Lagerstrom P O, et al. The pharmacokinetics of omeprazole in humans a study of single intravenous and oral doses[J]. Ther Drug Monit, 1990, 12(2):163.
9Uno T, Niioka T, Hayakari M, et al. Absolute bioavailability and metabolism of omeprazole in relation to CYP2C19 genotypes following single intravenous and oral administrations[J]. Eur J Clin Pharmacol, 2007, 63 (2):143.
10Duvauchelle T, Millerioux L, Gualano V, et al. Comparative bioavailability study of two oral omeprazole formula- tions after single and repeated administrations in healthy volunteers [J]. Clin Drug Investing, 1998,16(2) : 141.
